Skip to main content
Premium Trial:

Request an Annual Quote

Enzo's Q2 Revenues Increase 11 Percent; Legal Costs Hit Bottom Line

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market Friday that its second-quarter 2010 revenues had risen 11 percent, but its net loss increased 34 percent on legal costs.

The New York-based firm brought in total revenues of $23.2 million for the three-month period ended Jan. 31, compared to $20.9 million for the second quarter of 2009.

Revenues for the firm's life sciences division increased 11 percent to $12.6 million year over year, and its clinical labs revenue also increased 11 percent to $10.6 million.

Enzo's product revenues climbed to $10.8 million from $9.5 million year over year, while its royalty and license fee revenues were $1.8 million versus $1.9 million. Its clinical lab services revenue was $10.6 million, up from $9.5 million year over year.

Enzo's net loss for the quarter was $10.3 million, or $.27 per share, compared to a net loss of $7.7 million, or $.20 per share, for Q2 2009. A primary driver of the increased loss was a $3.7 million charge for litigation settlement and related legal costs. The firm had been sued by its former Secretary and Treasurer Shahram Rabbani, who was terminated by the firm in November 2009.

The company's R&D spending for the quarter increased around 5 percent to $2.3 million from $2.2 million, while its SG&A spending climbed 27 percent to $13.5 million from $10.6 million.

Enzo finished the quarter with $44.5 million in cash, cash equivalents, and short-term investments.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.